Cellular Dynamics International

Under the terms of the deal, Stemcell will distribute Cellular Dynamics' iCell line of induced pluripotent stem cell products.

The increase in revenues was driven by stem cell banking contracts and sales of iCell Hepatocytes.

NEW YORK (GenomeWeb) – Cellular Dynamics International today reported that its third quarter revenues increased 44 percent year over year.

NEW YORK (GenomeWeb) – Cellular Dynamics International today announced a $1.2 million contract from the National Eye Institute to manufacture stem cells for use in the development of a new potential treatment for dry age-related macular degeneration.

NEW YORK (GenomeWeb) – Cellular Dynamics International today reported that its second quarter revenues increased 29 percent year over year, but the firm missed Wall Street estimates on the top and bottom lines.

NEW YORK (GenomeWeb News) – Cellular Dynamics International today said that it has signed a deal to supply the Nestlé Institute of Health Sciences with its iCell and MyCell product lines.

NEW YORK (GenomeWeb News) – The Coriell Institute for Medical Research recently announced a $7.7 million contract extension from the National Institute for Neurological Disorders and Stroke to maintain the institute's biobank.

NEW YORK (GenomeWeb News) – Stem cell technology developer Cellular Dynamics International said today it has inked a collaborative agreement with the Hamner Institute to develop predictive in vitro screening assays to be used in toxicity testing and risk assessment.

NEW YORK (GenomeWeb News) – Cellular Dynamics will create five induced pluripotent stem cell lines from patients with muscular dystrophy for the Jain Foundation under a master service agreement announced today.

NEW YORK (GenomeWeb News) – Myriad Genetics said this week that BioMarin Pharmaceutical will use its BRACAnalysis test in its pivotal Phase 3 clinical study for BMN 673, an orally active PARP-inhibitor designed to induce synthetic lethality in BRCA-deficient cells.

Pages

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.